Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4742

Previous 25           Next 25
Website Changes
12/15/2015 Experimental drugs that change energy supply in cells could slow brain tumor growth
12/15/2015 Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
12/14/2015 New Data on Tumor Treating Fields’ Anti-Mitotic Mechanism of Action Published in Scientific Reports
12/14/2015 Roche`s Alecensa Granted Accelerated FDA Approval in Lung Cancer
12/13/2015 Patient with Brain Tumor Responds Dramatically to Targeted Therapy
12/12/2015 The Musella Foundation has awarded a pediatric brain tumor research grant
12/12/2015 A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.
12/12/2015 First Patient Enrolled in Toca 5, Tocagen’s Phase 2/3 Clinical Trial in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma
12/08/2015 Novocure (NVCR) Issues Positive Update on TTFields Study in Certain Glioblastoma Patients
11/27/2015 Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
11/27/2015 Experimental brain cancer treatment offers family hope
11/25/2015 The Musella Foundation announced that it has awarded a $50,000 brain tumor research grant to Ninh Doan, MD, PhD, of the Medical College of Wisconsin.
11/23/2015 Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs PFS but not OS
11/23/2015 Tocagen Presents Interim Data from Studies Evaluating Toca 511 & Toca FC at the Annual Meeting of the Society for Neuro-Oncology (SNO)
11/22/2015 Groundbreaking Global Brain Cancer Trial Planned
11/21/2015 ReACT: Long-term survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma
11/21/2015 Phase I/II Study of Dianhydrogalactitol (Val-083) in Patients with Recurrent Malignant Glioma
11/20/2015 Celldex vaccine improves long-term brain cancer survival in study
11/20/2015 New Phase 3 Data show Optune in Combination with Second Line Chemotherapy is Superior to Second Line Chemotherapy Alone in Glioblastoma Patients at First Recurrence
11/20/2015 ImmunoCellular Therapeutics Ltd Presents Updated ICT-107 Phase 2 Survival and Immune Response Data at the Society for Neuro-Oncology Annual Meeting 2015
11/18/2015 CURE Media Group’s Heroes of Glioblastoma Announced Today
11/18/2015 IBTA E-News
11/17/2015 Global brain cancer trial aims to rapidly respond to new treatments
11/17/2015 Drug That Could Limit Spread of Deadly Brain Tumours
11/17/2015 Novocure Announces 18 Presentations on Tumor Treating Fields at SNO 2015 Including New Analyses of the EF-14 Newly Diagnosed Glioblastoma Clinical Trial Data



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2016 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites